But it’s up to your specific plan to decide whether it covers a certain insulin drug, such as Basaglar. Basaglar is a long-acting insulin medication delivered through insulin pens called KwikPens.
The FDA has granted tentative approval for Basaglar (insulin glargine injection), produced by Eli Lilly and Boehringer Ingelheim's (BI) diabetes alliance, following litigation filed by Sanofi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback